Cargando…
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia(®)) in the Treatment of Recent-Onset Type 1 Diabetes
Our aim was to assess the efficacy, safety, and tolerability of alpha-1 antitrypsin (AAT) as a therapeutic modality for β-cell preservation in patients with recent-onset type 1 diabetes. Seventy type 1 diabetes patients (37 males; mean age 13.1 ± 4.1years) were randomized to treatment with 22 infusi...
Autores principales: | Lebenthal, Yael, Brener, Avivit, Hershkovitz, Eli, Shehadeh, Naim, Shalitin, Shlomit, Lewis, Eli C., Elias, Dana, Haim, Alon, Barash, Galia, Loewenthal, Neta, Zuckerman-Levin, Nehama, Stein, Michal, Tov, Naveh, Rachmiel, Marianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928874/ https://www.ncbi.nlm.nih.gov/pubmed/31795482 http://dx.doi.org/10.3390/ijms20236032 |
Ejemplares similares
-
Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown
por: Brener, Avivit, et al.
Publicado: (2020) -
Glycaemic Control in Children and Adolescents With Type 1 Diabetes Following a Single Telehealth Visit:What Have We Learned From the COVID-19 Lockdown?
por: Rachmiel, Marianna, et al.
Publicado: (2021) -
Glycaemic control in the paediatric and young adult population with type 1 diabetes following a single telehealth visit - what have we learned from the COVID-19 lockdown?
por: Rachmiel, Marianna, et al.
Publicado: (2021) -
Novel Susceptibility Genes Drive Familial Non-Medullary Thyroid Cancer in a Large Consanguineous Kindred
por: Majdalani, Pierre, et al.
Publicado: (2023) -
Pulmonary transplantation of alpha-1 antitrypsin (AAT)-transgenic macrophages provides a source of functional human AAT in vivo
por: Janosz, Ewa, et al.
Publicado: (2021)